Dr. Modesitt is the Director of the Gynecologic Oncology Division and the Co-Director of the High Risk Breast/Ovarian Cancer clinic at the University of Virginia. She is an Associate Professor and the Richard and Louise Crockett endowed Chair in Obstetrics and Gynecology. She completed her residency at the University of North Carolina and her fellowship at the M.D. Anderson Cancer Center. Dr. Modesitt served the Society of Gynecologic Oncology as Vice Chair of the Practice Survey Task force, Chair of the Candidate Task force and an Education Committee member. She was appointed to the Prolog Task force and Gynecologic Oncology Subcommittee for the American College of Obstetricians and Gynecologists. Dr. Modesitt is the UVA PI for the Gynecologic Oncology Group and is on the Safety Review and Developmental Therapeutics committees. Her research focuses on obesity related cancers, clinical trials and hereditary cancers.
Visit the Sisterhood of Survivorship page to read “Dena’s Story” — by a vulvar cancer survivor who has shared her story and wise words, and channeled her energy into her National Race to End Women’s Cancer team.
The CDC recently announced that fewer than half of American children are given the HPV vaccination.
As of the July 23 deadline, 55 research abstracts were submitted in hopes of receiving one of only 6 grants from the Foundation. This points to a need for more funding so that the Foundation may award grants to every deserving applicant.